Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22435 | 381 | 49.4 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
157 | 3 | JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY//BIOCHEMICAL RESEARCH METHODS//INTERNATIONAL JOURNAL OF MASS SPECTROMETRY | 61558 |
370 | 2 | PROTEOMICS//JOURNAL OF PROTEOME RESEARCH//BIOCHEMICAL RESEARCH METHODS | 17272 |
22435 | 1 | SECRETOME//90K MAC 2BP//GALECTIN 3 BINDING PROTEIN | 381 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SECRETOME | authKW | 1114328 | 25% | 15% | 95 |
2 | 90K MAC 2BP | authKW | 412170 | 2% | 86% | 6 |
3 | GALECTIN 3 BINDING PROTEIN | authKW | 341943 | 2% | 53% | 8 |
4 | 90K MAC 2 BINDING PROTEIN | authKW | 320578 | 1% | 100% | 4 |
5 | MAC 2 BINDING PROTEIN | authKW | 280499 | 2% | 50% | 7 |
6 | CANCER SECRETOME | authKW | 240434 | 1% | 100% | 3 |
7 | 90K | authKW | 213716 | 1% | 67% | 4 |
8 | LECTIN AFFINITY CAPTURE | authKW | 160289 | 1% | 100% | 2 |
9 | PROTEIN 90K | authKW | 160289 | 1% | 100% | 2 |
10 | TAA90K | authKW | 160289 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemical Research Methods | 4964 | 38% | 0% | 145 |
2 | Oncology | 388 | 18% | 0% | 69 |
3 | Biochemistry & Molecular Biology | 297 | 26% | 0% | 100 |
4 | Cell Biology | 70 | 9% | 0% | 34 |
5 | Immunology | 41 | 7% | 0% | 26 |
6 | Endocrinology & Metabolism | 36 | 5% | 0% | 19 |
7 | Chemistry, Analytical | 33 | 6% | 0% | 21 |
8 | Medicine, Research & Experimental | 29 | 4% | 0% | 17 |
9 | Biophysics | 27 | 4% | 0% | 16 |
10 | Medical Laboratory Technology | 9 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BASIC MED SCICELL CULTURE | 80145 | 0% | 100% | 1 |
2 | BASIC MED SCICORE RUMENT IL | 80145 | 0% | 100% | 1 |
3 | BEIJING TRADIT CHINESE MED BASIC PREV | 80145 | 0% | 100% | 1 |
4 | BIOACT GRP | 80145 | 0% | 100% | 1 |
5 | CEA MARCOULESBTNLBSP | 80145 | 0% | 100% | 1 |
6 | CELL BIOL PHYSISIOL IMMUNOL | 80145 | 0% | 100% | 1 |
7 | CORE RUMENT IL PHYSIOL PATHOPHYSIOL | 80145 | 0% | 100% | 1 |
8 | DIABET METAB ASSOCIATED DIS GRP | 80145 | 0% | 100% | 1 |
9 | DIP ONCOL NEUROSCI | 80145 | 0% | 100% | 1 |
10 | FISIOPATOL RIPROD UMANA | 80145 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PROTEOME RESEARCH | 29049 | 12% | 1% | 47 |
2 | PROTEOMICS | 12595 | 8% | 1% | 30 |
3 | PROTEOMICS CLINICAL APPLICATIONS | 10519 | 3% | 1% | 11 |
4 | MOLECULAR & CELLULAR PROTEOMICS | 8409 | 5% | 1% | 18 |
5 | JOURNAL OF PROTEOMICS | 7769 | 4% | 1% | 16 |
6 | EXPERT REVIEW OF PROTEOMICS | 2727 | 1% | 1% | 5 |
7 | BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 1622 | 2% | 0% | 8 |
8 | JOURNAL OF INFLAMMATION | 1013 | 0% | 1% | 1 |
9 | DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION | 488 | 1% | 0% | 2 |
10 | MOLECULAR ONCOLOGY | 426 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SECRETOME | 1114328 | 25% | 15% | 95 | Search SECRETOME | Search SECRETOME |
2 | 90K MAC 2BP | 412170 | 2% | 86% | 6 | Search 90K+MAC+2BP | Search 90K+MAC+2BP |
3 | GALECTIN 3 BINDING PROTEIN | 341943 | 2% | 53% | 8 | Search GALECTIN+3+BINDING+PROTEIN | Search GALECTIN+3+BINDING+PROTEIN |
4 | 90K MAC 2 BINDING PROTEIN | 320578 | 1% | 100% | 4 | Search 90K+MAC+2+BINDING+PROTEIN | Search 90K+MAC+2+BINDING+PROTEIN |
5 | MAC 2 BINDING PROTEIN | 280499 | 2% | 50% | 7 | Search MAC+2+BINDING+PROTEIN | Search MAC+2+BINDING+PROTEIN |
6 | CANCER SECRETOME | 240434 | 1% | 100% | 3 | Search CANCER+SECRETOME | Search CANCER+SECRETOME |
7 | 90K | 213716 | 1% | 67% | 4 | Search 90K | Search 90K |
8 | LECTIN AFFINITY CAPTURE | 160289 | 1% | 100% | 2 | Search LECTIN+AFFINITY+CAPTURE | Search LECTIN+AFFINITY+CAPTURE |
9 | PROTEIN 90K | 160289 | 1% | 100% | 2 | Search PROTEIN+90K | Search PROTEIN+90K |
10 | TAA90K | 160289 | 1% | 100% | 2 | Search TAA90K | Search TAA90K |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MAKRIDAKIS, M , VLAHOU, A , (2010) SECRETOME PROTEOMICS FOR DISCOVERY OF CANCER BIOMARKERS.JOURNAL OF PROTEOMICS. VOL. 73. ISSUE 12. P. 2291 -2305 | 46 | 46% | 102 |
2 | LIN, QF , TAN, HT , LIM, HSR , CHUNG, MCM , (2013) SIEVING THROUGH THE CANCER SECRETOME.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. VOL. 1834. ISSUE 11. P. 2360 -2371 | 42 | 42% | 8 |
3 | SCHAAIJ-VISSER, TBM , DE WIT, M , LAM, SW , JIMENEZ, CR , (2013) THE CANCER SECRETOME, CURRENT STATUS AND OPPORTUNITIES IN THE LUNG, BREAST AND COLORECTAL CANCER CONTEXT.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. VOL. 1834. ISSUE 11. P. 2242 -2258 | 35 | 33% | 27 |
4 | CLYNES, M , DOWLING, P , (2011) CONDITIONED MEDIA FROM CELL LINES: A COMPLEMENTARY MODEL TO CLINICAL SPECIMENS FOR THE DISCOVERY OF DISEASE-SPECIFIC BIOMARKERS.PROTEOMICS. VOL. 11. ISSUE 4. P. 794 -804 | 28 | 41% | 52 |
5 | PICCOLO, E , TINARI, N , D'ADDARIO, D , ROSSI, C , IACOBELLI, V , LA SORDA, R , LATTANZIO, R , D'EGIDIO, M , DI RISIO, A , PIANTELLI, M , ET AL (2015) PROGNOSTIC RELEVANCE OF LGALS3BP IN HUMAN COLORECTAL CARCINOMA.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 13. ISSUE . P. - | 17 | 71% | 1 |
6 | MENDEZ, O , VILLANUEVA, J , (2015) CHALLENGES AND OPPORTUNITIES FOR CELL LINE SECRETOMES IN CANCER PROTEOMICS.PROTEOMICS CLINICAL APPLICATIONS. VOL. 9. ISSUE 3-4. P. 348 -357 | 26 | 39% | 2 |
7 | PATEL, S , WETIE, AGN , DARIE, CC , CLARKSON, BD , (2014) CANCER SECRETOMES AND THEIR PLACE IN SUPPLEMENTING OTHER HALLMARKS OF CANCER.ADVANCEMENTS OF MASS SPECTROMETRY IN BIOMEDICAL RESEARCH. VOL. 806. ISSUE . P. 409 -442 | 33 | 30% | 6 |
8 | IACOVAZZI, PA , GUERRA, V , ELBA, S , SPORTELLI, F , MANGHISI, OG , CORREALE, M , (2003) ARE 90K/MAC-2BP SERUM LEVELS CORRELATED WITH POOR PROGNOSIS IN HCC PATIENTS? PRELIMINARY RESULTS.INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. VOL. 18. ISSUE 3. P. 222-226 | 20 | 57% | 8 |
9 | DORRUCCI, M , IACOBELLI, S , SULIGOI, B , PEZZOTTI, P , SINICCO, A , ANGARANO, G , TINARI, N , REZZA, G , (2004) LONGITUDINAL ANALYSIS OF THE 90K GLYCOPROTEIN IN THE ITALIAN HIV-SEROCONVERSION STUDY: TEMPORAL TREND AND PREDICTABILITY OF THE MATURITY OF HIV INFECTION.JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS. VOL. 18. ISSUE 1. P. 18-25 | 16 | 70% | 3 |
10 | TINARI, N , LATTANZIO, R , QUERZOLI, P , NATOLI, C , GRASSADONIA, A , ALBERTI, S , HUBALEK, M , REIMER, D , NENCI, I , BRUZZI, P , ET AL (2009) HIGH EXPRESSION OF 90K (MAC-2 BP) IS ASSOCIATED WITH POOR SURVIVAL IN NODE-NEGATIVE BREAST CANCER PATIENTS NOT RECEIVING ADJUVANT SYSTEMIC THERAPIES.INTERNATIONAL JOURNAL OF CANCER. VOL. 124. ISSUE 2. P. 333-338 | 16 | 59% | 6 |
Classes with closest relation at Level 1 |